Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas
Work
Year: 2021
Type: article
Abstract: BACKGROUNDLong-term prognosis of WHO grade II low-grade gliomas (LGGs) is poor, with a high risk of recurrence and malignant transformation into high-grade gliomas. Given the relatively intact immune ... more
Institutions University of California, San Francisco, Tokushima University, Neurological Surgery, UCSF Helen Diller Family Comprehensive Cancer Center, University of Minnesota +2 more
Cites: 43
Cited by: 49
Related to: 10
FWCI: 4.375
Citation percentile (by year/subfield): 76.84
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $5,200
Funders Parker Institute for Cancer Immunotherapy, Daiichi Sankyo Foundation of Life Science, National Institutes of Health
Grant IDS (Hideho Okada), (Hirokazu Ogino), 1R35NS105068